Revolutionary HIV Treatment: Lenacapavir Achieves 100% Clinical Efficacy
Lenacapavir, a groundbreaking HIV treatment, has achieved 100% clinical efficacy in preventing HIV infections in cisgender women, according to the PURPOSE 1 trial. This revolutionary treatment is administered twice-yearly, making it a game-changer for individuals who struggle with daily medication adherence. Key Findings: – 100% Efficacy: Lenacapavir demonstrated 100% efficacy in preventing HIV infections in … Read more